ACTRN12614001116617尚未招募未知
Effect of spironolactone on human brown fat in patients with primary aldosteronism
Professor Ken Ho0 个研究点目标入组 12 人开始时间: 2014年10月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Subjects with primary aldosteronism who will be treated with at least 4 weeks of spironolactone
排除标准
- 未提供
研究者
相似试验
已完成
4 期
Effect of spironolactone on brown fat activity in adult humansDiet and Nutrition - ObesityObesityACTRN12614001112651Professor Ken Ho10
尚未招募
不适用
Effect of Mineralocorticoid on Brown Fat in Humans with Primary Aldosteronism who will be treated with SurgeryPrimary aldosteronismDiet and Nutrition - ObesityMetabolic and Endocrine - Other metabolic disordersObesityACTRN12614001129673Professor Ken Ho12
已完成
不适用
The effect of Mirabegron on brown adipose tissue in healthy young white Caucasian and South Asian me10013317ObesitydyslipidemiaNL-OMON46185eids Universitair Medisch Centrum23
进行中（未招募）
1 期
Effect of Mirabegron on brown adipose tissueObesity and dyslipidemiaEUCTR2016-000237-48-NLeiden University Medical Center20
已完成
2 期
The effect of spironolactone in treatment of heart failureHeart Failure.Congestive heart failureIRCT2015101924597N1Vice chancellor for research of Iran university of medical sciences60